β-cyclodextrine methyl ethers
BETA W 7 M 1.8
|
411-120-1
|
-
|
-
|
-
|
-
|
-
|
1
|
-
|
-
|
-
|
-
|
Details
|
β-methyl-3-(1-methylethyl)benzenepropanal
FLORHYDRAL
|
412-050-4
|
125109-85-5
|
-
|
-
|
2
|
-
|
1
|
-
|
-
|
-
|
-
|
Details
|
γ-butyrolactone
|
202-509-5
|
96-48-0
|
-
|
-
|
1
|
-
|
-
|
1
|
-
|
-
|
-
|
Details
|
γ-cyclodextrine methyl esters
GAMMA W8 M 1.8
|
418-710-8
|
-
|
-
|
-
|
-
|
-
|
1
|
-
|
-
|
-
|
-
|
Details
|
γ-methylaziridine-1-propylamine
|
278-047-3
|
74993-03-6
|
-
|
-
|
-
|
-
|
1
|
-
|
-
|
-
|
-
|
Details
|
δ-valerolactone
|
208-807-1
|
542-28-9
|
-
|
-
|
1
|
-
|
-
|
-
|
-
|
-
|
-
|
Details
|
ε-caprolactam
|
203-313-2
|
105-60-2
|
-
|
-
|
1
|
-
|
-
|
-
|
-
|
-
|
-
|
Details
|
ε-Caprolactone, oligomeric reaction products with propylidynetrimethanol
|
500-099-5
|
37625-56-2
|
-
|
-
|
1
|
-
|
-
|
-
|
-
|
-
|
-
|
Details
|
λ²-iron(2+) lithium(1+) phosphate
|
476-700-9
|
1199808-36-0
|
-
|
-
|
1
|
-
|
-
|
-
|
-
|
-
|
-
|
Details
|
≥ 76.9% 3-[(1RS,3RS)-3-(4′-bromobiphenyl-4-yl)-3-hydroxy-1-phenylpropyl]-4-hydroxycoumarin and ≤ 23.1% 3-[(1RS,3SR)-3-(4′-bromobiphenyl-4-yl)-3-hydroxy-1-phenylpropyl]-4-hydroxycoumarin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
1
|
-
|
-
|
-
|
Details
|
(3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl)silanetriol and any of its mono-, di- or tri-O-(alkyl) derivatives
Triethoxy(3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl)silane
EC / List no:
257-473-3
| CAS no:
51851-37-7
Trimethoxy(3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl)silane
EC / List no:
288-657-1
| CAS no:
85857-16-5
|
-
|
-
|
-
|
-
|
-
|
-
|
1
|
-
|
-
|
-
|
1
|
Details
|
1,4-dichlorobenzene
|
203-400-5
|
106-46-7
|
-
|
-
|
1
|
-
|
1
|
-
|
-
|
-
|
1
|
Details
|
1,4-dioxane
|
204-661-8
|
123-91-1
|
-
|
1
|
-
|
-
|
2
|
1
|
1
|
-
|
1
|
Details
|
1,6,7,8,9,14,15,16,17,17,18,18-Dodecachloropentacyclo[12.2.1.16,9.02,13.05,10]octadeca-7,15-diene (“Dechlorane Plus”™)
covering any of its individual anti- and syn-isomers or any combination thereof
(1S,2S,5R,6R,9S,10S,13R,14R)-1,6,7,8,9,14,15,16,17,17,18,18-Dodecachloropentacyclo[12.2.1.1⁶,⁹.0²,¹³.0⁵,¹⁰]octadeca-7,15-diene
EC / List no:
-
| CAS no:
135821-03-3
(1S,2S,5S,6S,9R,10R,13R,14R)-1,6,7,8,9,14,15,16,17,17,18,18-Dodecachloropentacyclo[12.2.1.1⁶,⁹.0²,¹³.0⁵,¹⁰]octadeca-7,15-diene
EC / List no:
-
| CAS no:
135821-74-8
1,6,7,8,9,14,15,16,17,17,18,18-dodecachloropentacyclo[12.2.1.16,9.02,13.05,10]octadeca-7,15-diene
EC / List no:
236-948-9
| CAS no:
13560-89-9
rel-(1R,4S,4aS,6aS,7S,10R,10aR,12aR)-1,2,3,4,7,8,9,10,13,13,14,14-dodecachloro-1,4,4a,5,6,6a,7,10,10a,11,12,12a-dodecahydro-1,4:7,10-dimethanodibenzo[a,e]cyclooctene
EC / List no:
-
| CAS no:
-
rel-(1R,4S,4aS,6aR,7R,10S,10aS,12aR)-1,2,3,4,7,8,9,10,13,13,14,14-dodecachloro-1,4,4a,5,6,6a,7,10,10a,11,12,12a-dodecahydro-1,4:7,10-dimethanodibenzo[a,e]cyclooctene
EC / List no:
-
| CAS no:
-
|
-
|
-
|
-
|
1
|
-
|
-
|
1
|
-
|
1
|
1
|
1
|
Details
|
1-methyl-2-pyrrolidone
|
212-828-1
|
872-50-4
|
-
|
-
|
-
|
-
|
1
|
1
|
1
|
1
|
1
|
Details
|
2,4-dinitrotoluene
|
204-450-0
|
121-14-2
|
-
|
-
|
-
|
-
|
1
|
-
|
1
|
1
|
1
|
Details
|
Bis(pentabromophenyl) ether
|
214-604-9
|
1163-19-5
|
-
|
-
|
-
|
-
|
1
|
-
|
1
|
1
|
1
|
Details
|
Bisphenols with endocrine disrupting properties for the environment and their salts
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
1
|
Details
|
Calcium cyanamide
|
205-861-8
|
156-62-7
|
-
|
-
|
4
|
-
|
1
|
-
|
-
|
-
|
1
|
Details
|
Chromium VI compounds
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
1
|
Details
|
Chromium(VI) oxides and chromium(VI) oxyanion acids and salts
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
1
|
Details
|
Chrysotile
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
1
|
Details
|
cobalt carbonate; cobalt di(acetate); cobalt dichloride; cobalt dinitrate; cobalt sulphate
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
1
|
Details
|
Diisocyanates
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
1
|
Details
|
Dimethyl fumarate
|
210-849-0
|
624-49-7
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
1
|
Details
|
|
|
|
|
|
|
|
|
|
|
|
|
|